Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: Comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease

Pediatrics International

Volumn 55, Issue 5, 2013, Pages 578-581

  Shima, Yoshio ^a,b   Kumasaka, Sakae ^b   Migita, Makoto ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Japanese Red Cross Katsushika Maternity Hospital   (Japan)

Author keywords

bronchopulmonary dysplasia; chronic lung disease; small for gestational age

Indexed keywords

C REACTIVE PROTEIN; GLUCOCORTICOID;

ARTICLE; ASSISTED VENTILATION; BREATHING; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE COURSE; ECHOCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; GESTATIONAL AGE; HUMAN; INCIDENCE; LONG TERM CARE; LUNG DYSPLASIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN; NEWBORN INFECTION; NEWBORN PERIOD; OXYGEN SATURATION; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PERINATAL CARE; POSITIVE END EXPIRATORY PRESSURE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK FACTOR; SMALL FOR DATE INFANT;

BRONCHOPULMONARY DYSPLASIA; CHRONIC LUNG DISEASE; SMALL FOR GESTATIONAL AGE;

BRONCHOPULMONARY DYSPLASIA; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; JAPAN; LUNG DISEASES; MALE; OXYGEN INHALATION THERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84886088498     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12151     Document Type: Article

References (18)

1. Fanaroff AA, Hack M, Walsh MC,. The NICHD Neonatal Research Network: Changes in practice and outcomes during the first 15 years. Semin. Perinatol. 2003; 27: 281-287. (Pubitemid 37099808)
2. Parker RA, Lindstrom DP, Cotton RB,. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 1992; 90: 663-668. (Pubitemid 23008180)
3. Bancalari E, Claure N, Sosenko IR,. Bronchopulmonary dysplasia: Changes in pathogenesis, epidemiology and definition. Semin. Neonatol. 2003; 8: 63-71. (Pubitemid 36356494)
4. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM,. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-532.
5. Jobe A, Bancalari E, National Institute of Child Health and Human Development/National Heart, Lung, and Blood Institute/Office of Rare Diseases. Workshop summary: Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723-1729.
6. Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-1360. (Pubitemid 46056482)
7. Short EJ, Klein NK, Lewis BA, et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003; 112: e359.
8. Ogawa Y, Fujimura M, Goto A, et al. Epidemiology of chronic lung disease in Japan. Acta Pediatr. Jpn. 1992; 34: 663-667. (Pubitemid 23029105)
9. Ogawa Y, Iwamura T, Kuriya N, et al. Birth size standards by gestational age for Japanese neonates. J. Jpn. Soc. Perin. Neon. Med. 1998; 34: 624-632 (Japanese).
10. Kinsella JP, Greenough A, Abman SH,. Bronchopulmonary dysplasia. Lancet 2006; 367: 1421-1431.
11. Van Marter LJ,. Epidemiology of bronchopulmonary dysplasia. Semin. Fetal Neonatal Med. 2009; 14: 358-366.
12. Bancareli E, Claure N, Gonzalez A,. Patent ductus arteriosus and respiratory outcomes in premature infants. Biol. Neonate 2005; 88: 192-201. (Pubitemid 41433551)
13. Frank L, Lewis PL, Garcia-Pons T,. Intrauterine growth retarded rat pups show increased susceptibility to pulmonary oxygen toxicity. Pediatr. Res. 1985; 19: 281-286. (Pubitemid 15136995)
14. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM,. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 164: 1971-1980. (Pubitemid 33152338)
15. Lal MK, Manktelow BN, Draper ES, Field DJ,. Population-based study. Chronic lung disease of prematurity and intrauterine growth restriction: A population-based study. Pediatrics 2003; 111: 483-487. (Pubitemid 36330702)
16. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H,. Angiogenic factors and alveolar vasculature: Development and alterations by injury in very premature baboons. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002; 282: L811-823. (Pubitemid 34665598)
17. Reiss I, Landmann E, Heckmann M, Misselwitz B, Gortner L,. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch. Gynecol. Obstet. 2003; 269: 40-44. (Pubitemid 37408842)
18. Gortner L, Hilgendorff A, Baehner T, Ebsen M, Reiss I, Rudolff S,. Hypoxia-induced intrauterine growth retardation: Effects on pulmonary development and surfactant protein transcription. Biol. Neonate 2005; 88: 129-135. (Pubitemid 41159827)